Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by stockman6767on May 07, 2019 10:28pm
91 Views
Post# 29722783

AXCIENT WAS FUNDED BY tHOMVEST TRY RESEARCH IT AND SEE WHAT

AXCIENT WAS FUNDED BY tHOMVEST TRY RESEARCH IT AND SEE WHAT

HAPPENED TO IT?

Axcient Lands $15.5 Million For Affordable Backup And Data Protection Solution For SMBs

axcient_logo_finalrgb1

Axcient, the hybrid cloud-based data backup, disaster recovery, and business continuity startup, is today announcing that it has closed a $15.5 million round of series C funding. The round was led by Scale Venture Partners, the VC firm that has led investments in other cloud services companies like Box.net and DocuSign, with participation from previous investors like Allegis CapitalPeninsula Ventures, and Thomvest Ventures.

The series C investment brings Axcient’s  total funding to $33.5 million, and SaaS veteran and Scale Ventures Managing Director Rory O’Driscoll will be joining the startup’s board of directors as part of the investment. O’Driscoll also sits on the boards of companies like JasperSoft, Lumension Security, mBlox, Omniture, Picolight, ScanSafe and Vantage Media.

The company will be using its latest infusion of capital to triple the size of its marketing and sales team, roll out its services internationally, and grow its staff of 80 to 120+ over the next six months.

 

Bullboard Posts